The benchtop DNA printer developer DNA Script has expanded upon its most recent venture capital funding round, tacking on an additional $35 million for a grand total of $200 million. The financing ...
NEW YORK — Drug maker Imprimis Pharmaceuticals just found a backer to distribute its $1 alternative to Daraprim, the infection-fighting drug whose price was hiked 5,000% by Turing Pharmaceuticals.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results